Venture debt, revenue-based financing, grants and invoice finance. Money that does not cost equity — and does cost something else.
Non-dilutive funding is money that does not require selling equity:
Venture debt — a loan, usually alongside or after an equity round Revenue-based financing — repaid as a percentage of monthly revenue Invoice financing — borrowing against unpaid invoices Grants — non-repayable, usually for research or specific sectors Customer prepayment — the cheapest of all
Because equity is the most expensive money you will ever take, and founders often do not know the alternatives exist.
And because each of these has a different risk. Debt must be repaid on a schedule regardless of how the business is doing, and it usually ranks ahead of equity if things go wrong. Cheap until it is not.
A company with $30k MRR needs $300,000 to fund a sales hire and eighteen months of runway.
Equity — $300k for ~15%. No repayment obligation, no downside risk beyond dilution. The most expensive if the company succeeds; the safest if it does not.
Venture debt — $300k over 36 months at ~12%. No dilution beyond a small warrant. But roughly $10,000/month of repayments starting almost immediately, which reduces the runway the money was meant to buy. Usually only available after an equity round.
Revenue-based financing — $300k, repaid at 8% of monthly revenue until 1.4× is returned. Repayment flexes with performance, which is genuinely useful. Effective cost is high if you grow quickly.
Customer prepayment — persuade 10 customers onto annual upfront at a 15% discount. Roughly $306,000 in cash, costing about $54,000 in discount. No dilution, no debt, no investor. And it is a validation signal on top.
That last option is available to more companies than use it, and founders reliably overlook it because it does not feel like fundraising.
First-time founders often treat debt as free because it does not dilute. It is not free — it is a fixed obligation that continues whether or not the business performs, and it usually ranks ahead of equity in a bad outcome.
The second mistake: taking debt too early. Most venture debt is only available after an equity round, and taking on repayments pre-revenue is genuinely dangerous.
The third: never asking customers to pay upfront. It is the cheapest capital available and requires no lender, no investor and no paperwork beyond an invoice.
A discount for annual upfront. Cheapest capital available and it validates the product at the same time.
Research, climate, health and regional development grants are non-repayable. Slow and worth the application.
If the problem is genuinely timing rather than profitability, this is the matching tool.
It is designed to extend runway alongside equity, not to replace it.
A loan that buys twelve months and demands repayments from month two buys much less than twelve months.
Debt ahead of equity means lenders are paid before you are, in the outcome where it matters most.
Whenever you need capital. Working through these before defaulting to equity is worth an afternoon.
Avoid debt entirely pre-revenue and pre-product-market fit. Fixed obligations against uncertain revenue is how a survivable setback becomes fatal.
Apply this to your own startup in My Full Journey (free account).